{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:01:57Z","timestamp":1789621317980,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Netherlands Organisation for Scientific Research","doi-asserted-by":"crossref","award":["40-00506-98-9001"],"award-info":[{"award-number":["40-00506-98-9001"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"crossref"}]},{"name":"VIDI","award":["91713359"],"award-info":[{"award-number":["91713359"]}]},{"name":"VENI","award":["722.015.012"],"award-info":[{"award-number":["722.015.012"]}]},{"name":"Ministry of Health of Malaysia","award":["R02087"],"award-info":[{"award-number":["R02087"]}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"crossref","award":["AZV MZ CR 16-31932A"],"award-info":[{"award-number":["AZV MZ CR 16-31932A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"crossref"}]},{"name":"German Bundesministerium fuer Bildung und Forschung","award":["E-Rare-3"],"award-info":[{"award-number":["E-Rare-3"]}]},{"name":"German Bundesministerium fuer Bildung und Forschung","award":["1 U54 GM104940"],"award-info":[{"award-number":["1 U54 GM104940"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.trsl.2018.04.008","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T09:02:57Z","timestamp":1525942977000},"page":"62-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Intact transferrin and total plasma glycoprofiling for diagnosis and therapy monitoring in phosphoglucomutase-I deficiency"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6818-7973","authenticated-orcid":false,"given":"Nurulamin","family":"Abu Bakar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol C.","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Marquardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian C.H.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Hansikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Crushell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Sykut-Cegielska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Bowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"M\u00d8rkrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Morava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"van Scherpenzeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"Lefeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2018.04.008_bib0001","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMc0901158","article-title":"Muscle glycogenosis due to phosphoglucomutase 1 deficiency","volume":"361","author":"Stojkovic","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2018.04.008_bib0002","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1093\/hmg\/dds123","article-title":"Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing","volume":"21","author":"Timal","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2018.04.008_bib0003","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1206605","article-title":"Multiple phenotypes in phosphoglucomutase 1 deficiency","volume":"370","author":"Tegtmeyer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2018.04.008_bib0004","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymgme.2014.06.002","article-title":"Galactose supplementation in phosphoglucomutase-1 deficiency; review and outlook for a novel treatable CDG","volume":"112","author":"Morava","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2018.04.008_bib0005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.nmd.2017.01.014","article-title":"PGM1 deficiency: substrate use during exercise and effect of treatment with galactose","volume":"27","author":"Voermans","year":"2017","journal-title":"Neuromusc Disord : NMD"},{"key":"10.1016\/j.trsl.2018.04.008_bib0006","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/gim.2017.41","article-title":"Oral D-galactose supplementation in PGM1-CDG","volume":"19","author":"Wong","year":"2017","journal-title":"Genet Med : Off J Am College Med Genet"},{"key":"10.1016\/j.trsl.2018.04.008_bib0007","first-page":"137","article-title":"Glycogen storage disease-like phenotype with central nervous system involvement in a PGM1-CDG patient","volume":"35","author":"Ondruskova","year":"2014","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.trsl.2018.04.008_bib1008","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpeds.2016.04.021","article-title":"Defining the Phenotype and Assessing Severity in Phosphoglucomutase-1 Deficiency","volume":"175","author":"Wong","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.trsl.2018.04.008_bib0008","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ajhg.2015.12.010","article-title":"CCDC115 Deficiency Causes a Disorder of Golgi Homeostasis with Abnormal Protein Glycosylation","volume":"98","author":"Jansen","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2018.04.008_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2015.07.005","article-title":"High-resolution mass spectrometry glycoprofiling of intact transferrin for diagnosis and subtype identification in the congenital disorders of glycosylation","volume":"166","author":"van Scherpenzeel","year":"2015","journal-title":"Transl Res : J Lab Clin Med"},{"key":"10.1016\/j.trsl.2018.04.008_bib0010","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1021\/pr100202a","article-title":"Human serum processing and analysis methods for rapid and reproducible N-glycan mass profiling","volume":"9","author":"Kronewitter","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1016\/j.trsl.2018.04.008_bib0011","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.chroma.2012.12.079","article-title":"Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer","volume":"1279","author":"Hua","year":"2013","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.trsl.2018.04.008_bib0012","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1373\/clinchem.2010.153635","article-title":"Plasma N-glycan profiling by mass spectrometry for congenital disorders of glycosylation type II","volume":"57","author":"Guillard","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.trsl.2018.04.008_bib0013","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ab.2013.07.037","article-title":"Serum N-glycan and O-glycan analysis by mass spectrometry for diagnosis of congenital disorders of glycosylation","volume":"442","author":"Xia","year":"2013","journal-title":"Anal Biochem"},{"key":"10.1016\/j.trsl.2018.04.008_bib0014","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/glycob\/cwg040","article-title":"Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I","volume":"13","author":"Callewaert","year":"2003","journal-title":"Glycobiology"},{"key":"10.1016\/j.trsl.2018.04.008_bib0015","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/glycob\/cwj021","article-title":"Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia","volume":"15","author":"Sturiale","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.trsl.2018.04.008_bib0016","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/bit.10022","article-title":"Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells","volume":"75","author":"Hills","year":"2001","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.trsl.2018.04.008_bib0017","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1002\/bit.23200","article-title":"Effects of cell culture conditions on antibody N-linked glycosylation\u2013what affects high mannose 5 glycoform","volume":"108","author":"Pacis","year":"2011","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.trsl.2018.04.008_bib0018","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/bit.20317","article-title":"Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures","volume":"89","author":"Chee Furng Wong","year":"2005","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.trsl.2018.04.008_bib0019","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/bit.25924","article-title":"Mannose metabolism in recombinant CHO cells and its effect on IgG glycosylation","volume":"113","author":"Slade","year":"2016","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.trsl.2018.04.008_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001256","article-title":"Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation","volume":"6","author":"Lauc","year":"2010","journal-title":"PLos Genet"},{"key":"10.1016\/j.trsl.2018.04.008_bib0021","doi-asserted-by":"crossref","first-page":"11094","DOI":"10.18632\/oncotarget.14362","article-title":"Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524418300732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524418300732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T20:35:30Z","timestamp":1604262930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524418300732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":22,"alternative-id":["S1931524418300732"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2018.04.008","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intact transferrin and total plasma glycoprofiling for diagnosis and therapy monitoring in phosphoglucomutase-I deficiency","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2018.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}